首页> 外文期刊>BMC Nephrology >Rs10887800 renalase gene polymorphism influences the level of circulating renalase in patients undergoing hemodialysis but not in healthy controls
【24h】

Rs10887800 renalase gene polymorphism influences the level of circulating renalase in patients undergoing hemodialysis but not in healthy controls

机译:Rs10887800肾酶基因多态性影响血液透析患者的循环肾酶水平,但对健康对照者没有影响

获取原文
           

摘要

Background Human renalase (RNLS), a recently identified flavoprotein with oxidoreductase activity, is secreted into blood by kidneys and metabolizes circulating catecholamines. Recent studies have revealed that common polymorphisms in RNLS gene might affect the risk of several cardiovascular conditions in hemodialyzed patients. However, the exact mechanism underlying this link remains unclear. The study aims to investigate the association between RNLS gene polymorphisms and plasma renalase level in ESKD patients undergoing hemodialysis (HD group) and healthy controls (HC). Methods A total of 309 hemodialyzed patients and 90 controls were enrolled in the study. All the participants were genotyped for two RNLS SNPs (rs2576178 and rs10887800) using PCR-RFLP method. Plasma renalase concentrations were determined by enzyme-linked immunosorbent assay (USCN Life Science Inc., Wuhan, China). The IBM SPSS Statistics for Windows, version 20 (IBM Corp., Armonk, NY, USA) was used for statistical analyses. Results Genotype distribution and allele frequencies of studied SNPs did not differ between two analyzed groups, p >?.050. RNLS concentration in HD group (33.54?μg/mL) was significantly higher than in HC (13.16?μg/mL), p ?.050. Interestingly, in HC group rs10887800 polymorphism did not influence RNLS concentration. Rs2576178 SNP did not affect the level of plasma RNLS either in HD group or in HC. Conclusion Rs10887800 polymorphic variant of RNLS gene influences the level of circulating RNLS in patients undergoing hemodialysis, and thus elucidates the potentially functional relevance of this polymorphism in HD population.
机译:背景技术人肾病酶(RNLS)是一种最近发现的具有氧化还原酶活性的黄素蛋白,它被肾脏分泌到血液中并代谢循环中的儿茶酚胺。最近的研究表明,RNLS基因常见的多态性可能会影响血液透析患者发生几种心血管疾病的风险。但是,仍不清楚此链接的确切机制。这项研究旨在调查接受血液透析(HD组)和健康对照(HC)的ESKD患者的RNLS基因多态性与血浆肾酶水平之间的关系。方法共有309名血液透析患者和90名对照参加了研究。所有参与者均使用PCR-RFLP方法对两个RNLS SNP(rs2576178和rs10887800)进行基因分型。通过酶联免疫吸附测定法(USCN Life Science Inc.,武汉,中国)测定血浆肾酶浓度。 Windows的IBM SPSS Statistics版本20(IBM Corp.,Armonk,NY,美国)用于统计分析。结果在两个分析组之间,研究的SNP的基因型分布和等位基因频率没有差异,p> ?. 050。 HD组的RNLS浓度(33.54μg/ mL)显着高于HC组(13.16μg/ mL),p≤0.05。有趣的是,在HC组中rs10887800的多态性不会影响RNLS的浓度。 Rs2576178 SNP在HD组或HC组均不影响血浆RNLS水平。结论RNLS基因的Rs10887800多态性变异影响血液透析患者循环RNLS的水平,从而阐明该多态性在HD人群中的潜在功能相关性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号